DNDi accelerates life-saving drug discovery research in dengue

Geneva headquartered Drugs for Neglected Disease initiative (DNDi), a not-for-profit research and development (R&D) organisation focusing on neglected diseases, has announced a collaboration with BenevolentAI for a joint research project to tackle dengue, one of the world’s most prevalent infectious diseases. The project will combine the Benevolent Platform with DNDi’s expertise and global network of partners in dengue to empower researchers to uncover insights they would not have been able to find using human reasoning alone. Using a data foundation built from diverse and independent data sources, such as scientific literature, patents, genetics, chemistry, clinical trial data and more, scientists from BenevolentAI and DNDi will use AI tools to interrogate the underlying mechanisms involved in dengue, better frame hypotheses and rapidly identify targets or therapies that could be repurposed to prevent progression to severe dengue.